Evaluation of Matrix Tablets Based on Eudragit®E100/Carbopol®971P Combinations for Controlled Release and Improved Compaction Properties of Water Soluble Model Drug Paracetamol

AAPS PharmSciTech
Wasfy M ObeidatHatim Alkhatib

Abstract

The purpose of this work was to investigate the influence of Eudragit®E100 polymer in modifying the release rates and compaction properties of water soluble model drug paracetamol from Carbopol®971P NF polymer matrix tablets prepared by direct compression. The effects of the ratio of the two polymers, the total polymeric content, and the tablets mechanical strength on paracetamol release rates were investigated. Dissolution studies were conducted using USP XX Π rotating paddle apparatus at 50 rpm and 37°C at three different stages (pH 1.2, 4.8, and 6.8). Results showed that the polymers combination improved significantly the compaction properties of paracetamol tablets as evident by the higher crushing strengths (8.3 ± 0.4 Kp) compared to polymer-free tablets (3.4 ± 0.2 Kp) at intermediate compression pressure of 490 MPa. When combined with Carbopol®971P NF, Eudragit®E100 was found to be capable of extending paracetamol release for more than 12 h compared to 1 h for polymers-free tablets. The combined polymers were able to control paracetamol release in a pH independent pattern. The f2 (similarity factor) analysis showed that the ratio between the polymers and the total polymer concentration exhibited significant impact on drug...Continue Reading

References

Apr 20, 1977·European Journal of Clinical Pharmacology·M D RawlinsA R Hijab
Jun 1, 1982·The Journal of Pharmacy and Pharmacology·A McKenna, D F McCafferty
Nov 1, 1996·The Journal of Pharmacy and Pharmacology·A NokhodchiM H Rubinstein
Dec 24, 1998·Journal of Controlled Release : Official Journal of the Controlled Release Society·M V VelascoA R Rajabi-Siahboomi
Sep 30, 1999·International Journal of Pharmaceutics·J Y JungK H Lee
Jun 7, 2000·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·R Löbenberg, G L Amidon
Jun 7, 2000·Pharmaceutical Science & Technology Today·P ColomboN A Peppas
Apr 12, 2001·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·P Costa, J M Sousa Lobo
Apr 16, 2002·Neonatal Network : NN·B Noerr
Sep 25, 2004·Journal of Pharmaceutical Sciences·Marina Levina, Ali R Rajabi-Siahboomi
May 27, 2006·Journal of Pharmaceutical Sciences·Aditya S Tatavarti, Stephen W Hoag
Jun 24, 2008·Drug Development and Industrial Pharmacy·Wasfy M ObeidatAl-Sayed A Sallam
Aug 6, 2010·Biological & Pharmaceutical Bulletin·Yi-Dong YanHan-Gon Choi
Mar 23, 2011·Drug Development and Industrial Pharmacy·Fu JijunTang Xing
Apr 26, 2012·International Journal of Pharmaceutics·Kai ShiinoShigeru Itai
Feb 20, 2013·International Journal of Pharmaceutics·Yoshinori NakanoNoriyuki Namiki

❮ Previous
Next ❯

Citations

Mar 14, 2019·The Journal of Antimicrobial Chemotherapy·Sahana VasudevanAdline Princy Solomon
Dec 17, 2015·Postgraduate Medicine·Ajay Vallakati, William R Lewis
Mar 25, 2017·Journal of Materials Science. Materials in Medicine·Wenyan LiXiaole Qi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.